Dental Care Clinics in Medford, MA Accepting Medicare
47 Dental Care Clinics found. Showing 41 - 47
 Aspen Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 678 Fellsway, Medford, MA 02155 Phone: 781-391-8979 |
Raffi Bagdassarian Dmd, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 411 High St, Medford, MA 02155 Phone: 781-396-7707 |
Perrotta Dental, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 84 High St, Suite 203, Medford, MA 02155 Phone: 781-391-2988 |
Isabelle Jaillet Dmd Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 397 Main St, Medford, MA 02155 Phone: 781-396-1231 |
Yavner Dental Associates Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 Main Street, Suite #220, Medford, MA 02155 Phone: 781-396-2179 |
Dental Clinical Solutions Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 92 High St Ste Dh12, Medford, MA 02155 Phone: 781-396-4131 Fax: 781-396-2064 |
Medford Dental Associates, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 Main St Ste 206, Medford, MA 02155 Phone: 781-395-5545 |
News Archive
Research provides answers to issues related to human pathogens in mushroom growth substrate
Strict requirements on the use of animal manures in fresh produce production imposed by the new federal food-safety law threatened to adversely impact the mushroom industry, which relies on horse and poultry manure for a specialized growth substrate.
Isis, Genzyme submit European MAA for mipomersen to treat familial hypercholesterolemia
Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc. today announced that Genzyme has submitted a marketing authorization application (MAA) to the European Medicines Agency seeking approval for the 200 mg weekly dose of mipomersen for the treatment of homozygous and severe heterozygous familial hypercholesterolemia.
Saint Mary's, Mercy Health and VAI sign agreements to expand biorepository
Van Andel Institute (VAI) and two West Michigan hospitals within the national Trinity Health system and members of Mercy Health - Saint Mary's Health Care and Mercy Health Partners - have signed agreements paving the way for the expansion of a world-class biorepository utilizing the infrastructure of the VAI Program for Biospecimen Science.
iGetBetter joins Massachusetts Hospital Association to reduce hospital readmissions
iGetBetter, a supplier of post-acute care transition solutions designed to help reduce hospital readmissions, and the Massachusetts Hospital Association (MHA), the primary representative of the hospital community in the commonwealth, announced today that iGetBetter will join MHA and contribute to efforts now underway by Massachusetts hospitals to improve post-discharge care transition and reduce hospital readmissions.
Pivotal Phase 3 IMPACT study results of PROVENGE published in New England Journal of Medicine
Dendreon Corporation announced today the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine, showing that PROVENGE (sipuleucel-T) demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostate cancer. The manuscript is published in the July 29, 2010 issue of the journal.
› Verified 1 days ago